 initi delayed-typ hypersensit low dose monoclon ige antibodi mediat serotonin inhibit histamin elicit delayed-typ hypersensit dth respons dth effector cell prior phase dth initi immedi hypersensitivity-lik respons ag-specif dth-initi factor analog ige antibodi tissu mast cell releas vasoact amin serotonin experi ige mab dth small dose ige microgram/mous ng small immedi respons optim dth initi dose ige ng/mous measur immedi respons capabl dth initi dose ige micrograms/mous larg immedi respons abl dth similar dose respons dth initi mab mast cell-sensit isotyp Ig inabl high dose ige dth initi local releas larg inhibitori amount histamin system treatment receptor antagonist cimetidin high dose ige dth thu ige antibodi dth releas small amount simultan releas larg amount histamin inhibitori effect receptor recruit cell follow ige antibodi dth dth initi detect earli respons mast cell releas act wherea releas histamin act murin dth ag-specif factor mechan dth initi